2022-05-26 | NDAQ:OCX | Press Release | ONCOCYTE CORPORATION

(2022-05-26 | NDAQ:OCX) Oncocyte Presents DetermaIO(TM) Data at ASCO 2022 Supporting the Test's Potential to Expand the Clinical Use of Immunotherapy

Related Keywords

United States ,Chicago ,Illinois ,American ,Heinz Josef Lenz ,Rob Seitz ,Oncocyte Closecurlyquote ,Charu Aggarwal ,David Gandara ,Priyanka Sharma ,Megan Kernan ,Chiara Cremolini ,Md Uc Davis Comprehensive Cancer Center ,Early Access Program ,Cancer Foundation ,Abramson Cancer Center ,Exchange Commission ,American Society Of Clinical Oncology Annual Meeting ,Asian Cancer Research Group ,Company Closecurlyquote ,Oncocyte Corporation ,Norris Comprehensive Cancer Center ,University Of Pennsylvania ,Oncocyte Corporation Nasdaq ,Md University Of Kansas Medical Center ,Cancer Genome Atlas Program ,American Society ,Clinical Oncology Annual Meeting ,Marcia Mataldi Endowed Merit Award ,Conquer Cancer Foundation ,Principal Investigator ,Immune Oncology ,Continuing Medical Education Event ,Molecular Diagnostics ,Tumor Microenvironment ,Improve Personalized Medicine ,Colorectal Cancers ,Comprehensive Cancer Center ,Kansas Medical Center ,Conquer Cancer ,Factors Closecurlydoublequote ,Healthcare 37 ,Biotechnology 121 ,Usa 8 ,Biotechnology 70569 ,